Designing better coumarin-based fluorogenic substrates for PTP1B
Authors:
- Christopher P. HolmesCHChristopher P. Holmes
- Natalie MacherNMNatalie Macher
- J. Russell GroveJGJ. Russell Grove
- Larry JangLJLarry Jang
- Jennifer D. IrvineJIJennifer D. Irvine
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (11) , 3382-3385
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- PTP1B inhibitors: Synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffoldBioorganic & Medicinal Chemistry Letters, 2008
- PTP1B as a drug target: recent developments in PTP1B inhibitor discoveryDrug Discovery Today, 2007
- Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasisNature Genetics, 2007
- Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1BMedicinal Research Reviews, 2006
- Discovery and structure–activity relationships of novel sulfonamides as potent PTP1B inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Crystal Structure of the PTPL1/FAP-1 Human Tyrosine Phosphatase Mutated in Colorectal CancerJournal of Biological Chemistry, 2005
- Protein tyrosine phosphatase: enzymatic assaysMethods, 2005
- Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and ObesityCurrent Pharmaceutical Design, 2004
- α,α-Difluoro-β-ketophosphonates as potent inhibitors of protein tyrosine phosphatase 1BBioorganic & Medicinal Chemistry Letters, 2004
- Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor designProceedings of the National Academy of Sciences, 1997